ArticlePloS one2025
Utilizing a deep learning model based on BERT for identifying enhancers and their strength.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hematopoietic stem cell aging: a review of transcriptional and multi-omics insights and potential paths for AI integration.Experimental & molecular medicine · 2026Review
- Dense retrieval and reranking for referenced provisions in electric power audit systems.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An enhancer is a specific DNA sequence typically located within a gene at upstream or downstream position and serves as a pivotal element in the regulation of eukaryotic gene transcription. Therefore, the recognition of enhancers is highly significant for comprehending gene expression regulatory systems. While some useful predictive models have been proposed, there are still deficiencies in these models. To address current limitations, we propose a model, DNABERT2-Enhancer, based on transformer architecture and deep learning, designed for the recognition of enhancers (classified as either enhancer or non-enhancer) and the identification of their activity (strong or weak enhancers). More specifically, DNABERT2-Enhancer is composed of a BERT model for extracting features and a CNN model for enhancers classification. Parameters of the BERT model are initialized by a pre-training DNABERT-2 language model. The enhancer recognition task is then fine-tuned through transfer learning to convert the original sequence into feature vectors. Subsequently, the CNN network is employed to learn the feature vector generated by BERT and produce the prediction results. In comparison with existing predictors utilizing the identical dataset, our approach demonstrates superior performance. This suggests that the model will be a useful instrument for academic research on the enhancer recognition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.